Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.6800
-0.0300 (-4.23%)
At close: Feb 16, 2026
Market Cap151.07M -1.0%
Revenue (ttm)211.93M -1.1%
Net Income13.52M +8.3%
EPS0.04 +8.2%
Shares Out222.16M
PE Ratio15.15
Forward PEn/a
Dividend0.03 (3.68%)
Ex-Dividend DateJan 16, 2026
Volume4,000
Average Volume102,850
Open0.6800
Previous Close0.7100
Day's Range0.6800 - 0.6800
52-Week Range0.5800 - 0.7350
Beta0.14
RSI46.77
Earnings DateFeb 20, 2026

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services. It also conducts research and development in biotechnology; distributes human healthcare and related products; wholesales and distributes pharmaceu... [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 205
Stock Exchange Bursa Malaysia
Ticker Symbol RHONEMA
Full Company Profile

Financial Performance

In 2024, Rhone Ma Holdings Berhad's revenue was 211.41 million, an increase of 4.17% compared to the previous year's 202.93 million. Earnings were 12.31 million, an increase of 1.87%.

Financial Statements